4/A: Skye Bioscience CFO Corrects Shareholding Figures After Stock Sales to Cover Tax Obligations

Kaitlyn Arsenault, CFO of Skye Bioscience, files an amended Form 4 to correct a typographical error in the previously reported number of shares held after selling shares to cover tax withholding obligations.

Summary

• Kaitlyn Arsenault, the Chief Financial Officer of Skye Bioscience, Inc., filed an amended Form 4 with the SEC.
• This amendment corrects a typographical error in the original filing regarding the number of shares held following recent transactions.
• The transactions involved the sale of common stock to cover tax withholding obligations related to the vesting and settlement of performance-based restricted stock units.
• On November 15, 2024, 190 shares were sold at $5.55 per share.
• On November 18, 2024, 43,026 shares were sold at a weighted average price of $4.99 per share (ranging from $4.98 to $5.08).
• Following these transactions, the CFO directly owns 167,522 shares of common stock, correcting the previously reported 166,342 shares.

Sentiment

Score: 7

Explanation: The document is a routine regulatory filing correcting a minor error. The stock sales are related to tax obligations, which is a normal occurrence. Overall, the sentiment is neutral to slightly positive due to the transparency and correction of information.

Positives

• The amendment ensures accurate reporting of the CFO's shareholdings.
• The sales were to cover tax obligations, which is a common practice upon vesting of restricted stock units.

Industry Context

Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, ensuring transparency in the market.

Comparison to Industry Standards

• CFO stock sales to cover tax obligations are a common practice across the industry.
• Similar transactions are regularly reported by executives at comparable companies in the biotech sector, such as Corcept Therapeutics or Cara Therapeutics, following vesting of stock options or restricted stock units.
• The weighted average price execution is also standard, with block trades often executed across a range of prices.

Stakeholder Impact

• Shareholders benefit from accurate reporting of insider transactions.
• The transactions themselves have a minimal impact on the company's operations or financial position.

Key Dates